This document is a USPTO patent application (US20260083769A1) for "2-Aminopropane-1,3-Diol-Capped Cationic Peptoids for Nucleic Acid Delivery." The application, filed on September 8, 2023, by inventors Colin James McKinlay, Nicole PECK, Timothy BLAKE, and Juan ECHEVERRI, discloses compositions comprising hydroxyalkyl-capped cationic peptoids, specifically 2-aminopropane-1,3-diol-capped ones, and their complexes with polyanionic compounds like nucleic acids. These are intended for use in methods of making and using delivery vehicle compositions and complexes for delivering polyanionic compounds to cells and for eliciting immune responses.

As this is a patent application, it does not impose direct compliance obligations on regulated entities. However, it signals potential future developments in drug delivery and biotechnology. Companies involved in nucleic acid therapeutics, gene therapy, or vaccine development should monitor patent filings in this area for potential intellectual property implications and emerging technologies. No specific compliance deadlines or penalties are associated with patent applications.